Navigation Links
LifeCell Reports Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

PRODUCT REVENUES UP 35% VERSUS FULL YEAR 2006

BRANCHBURG, N.J., Feb. 27 /PRNewswire-FirstCall/ -- LifeCell Corporation (Nasdaq: LIFC) today reported financial results for the fourth quarter and full year ended December 31, 2007. Paul Thomas, President and Chief Executive Officer, will host a conference call today at 10:00 a.m. Eastern to discuss the fourth quarter and full year financial results.

Fourth Quarter 2007 Results

Product revenues for the fourth quarter were $52.6 million, up 34%, compared to $39.3 million reported for the same period in 2006. The increase in product revenue was primarily due to an increase in demand for the Company's flagship reconstructive surgical product, AlloDerm(R) Regenerative Tissue Matrix, which increased 38% to $46.9 million in the current quarter compared to $33.9 million in the fourth quarter of 2006. Orthopedic product revenues, which include GraftJacket(R) and AlloCraft(TM)DBM, increased 13% to $3.1 million in the quarter from $2.8 million in the fourth quarter of 2006. Repliform(R) revenues decreased in the quarter to $1.9 million from $2.1 million in the same quarter in 2006.

Operating income for the fourth quarter of 2007 decreased 1% to $9.3 million compared to operating income of $9.4 million in the fourth quarter of 2006. Operating income in the fourth quarter of 2007 was negatively impacted by higher than normal legal fees and the previously announced settlement of a non-product related claim.

Net income for the fourth quarter of 2007 was $5.5 million, or $0.16 per diluted share, compared to net income of $6.2 million, or $0.18 per diluted share in the fourth quarter of 2006. The settlement noted above reduced diluted net income per share by appr
'/>"/>

SOURCE LifeCell Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
2. AMN Healthcare Reports Fourth Quarter and Year End 2007 Results; Provides Full Year 2008 Guidance
3. DATATRAK International Reports Fourth Quarter and Full Year Results for 2007
4. Claimsnet.com Reports Fiscal Year 2007 Results
5. Unilens Vision Reports 70% Increase in Second Quarter Earnings on Higher Sales and Record Royalty Income
6. Caliper Life Sciences Reports Fourth Quarter and Full Year 2007 Results
7. 012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007
8. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
9. NHP Reports Fourth Quarter and Full Year 2007 Earnings
10. High Calcium Intake May Not Help Prevent Fractures, Reports The Harvard Health Letter
11. Clarity for Consumers on Botox Complication and Death Reports

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...lif., Dec. 4 Herpes zoster, also k...have been vaccinated against chicken pox, accordin...ue of the Pediatric Infectious Diseases Journal. ...ectronic health records to identify more than 170,...n pox) vaccine from 2002 to 2008 in Kaiser Permane...
(Date:12/3/2009)...Mass., Dec. 3 The Cancer Center ...irst patients, Harrington Hospital announced today...ately," said Diane Becquart, Director of The Cance...nted today by the Massachusetts Department of Publ... the facility. ,, The opening of The Cancer Ce...
(Date:12/3/2009)...c. 3 The American Medic...ed States District Court for the Southern District...he previously disclosed $350 million settlement th...itedHealth Group. ,, The action brought by the ...Missouri State Medical Association, along with sev...
(Date:12/3/2009)...dely used sulfonylureas, but each patient will be .... 3 (HealthDay News) -- A class of drugs still ta...associated with a higher risk of dying and heart f...hers say. , , Sulfonylureas, long a mainstay of...ormin in a study of oral anti-diabetes drugs, but ...
(Date:12/3/2009)... Evaluation and Treatment Clinics Also Remain Ope...ember 3, 2009 -- Centegra Health System is continu...shots at four Centegra Primary Care (CPC) vaccina...s arrived. The clinics are at CPC sites in Huntley...open as follows: ,   From 4:30 to 7:30 ...
Breaking Medicine News(10 mins):Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Cancer Center at Harrington to Begin Seeing Patients 2Health News:Cancer Center at Harrington to Begin Seeing Patients 3Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2Health News:Diabetes Drugs Go Head-to-Head in Study 2Health News:Diabetes Drugs Go Head-to-Head in Study 3Health News:Centegra H1N1 Vaccination Clinics Continue 2Health News:Centegra H1N1 Vaccination Clinics Continue 3Health News:Centegra H1N1 Vaccination Clinics Continue 4
...hy kidney from a cancer patient, in Scotland has r...s //. Scottish National Party MSP, Alex Neil has u... of the involved surgeon. He further intends... be taken against the offenders. 'We now need answ...
...dex as a tool and indicator of diet is being quest... foods. High-GI foods, like white bread and potato...and some studies have suggested that diets heavy i...ted blood sugar and diabetes have not been found b...
...ce to fill up the healthcare sector, which runs sh... recruitment not only fills // up the void but als...ove is based on the recommendations of a recent re...growing opportunities with India emerging as a maj...
...ed to antibiotics in the first year of their life ... Carlo Marra and other researchers at the Univers...n and 1,817 asthma cases found this, but suggested...ch case antibiotics are not useful, reported healt...
...nd under weather, when the weather is down- winter...gap between feeling low and depression, according ...affects nearly one in every ten people in the Unit...illness, and life at that time can seem absolutely...
...er, who is over the board regularly, its time to c...o kick the tendency. // Medical experts have issue...s, a disease of the liver is not far away, and is ...lly with those under the age of 45, since the year...
Other Medicine News:Health News:Bottleneck: High on Spirits Can Cause A Dispirited Liver, Leading To Cirrhosis! 2
(Date:12/3/2009)...c. 3 Cardium Therapeutic...ly-owned subsidiary, Tissue Repair Company, submit...e U.S. Food and Drug Administration (FDA) seeking ...t candidate based on positive data from the Compan...udy. Today,s submission with the FDA covers Excel...
(Date:12/3/2009)... Dec. 3 Apnex Medical, Inc., a pri... completed a second round of private equity financ...o complete a clinical study and develop a second g...y designed to treat obstructive sleep apnea (OSA)....n Associates, New Enterprise Associates (NEA), Pol...
(Date:12/3/2009)...f., Dec. 3 Jazz Pharmace...t Kathryn E. Falberg has been appointed Senior Vic...erg brings to Jazz Pharmaceuticals more than 20 ye... As Jazz Pharmaceutical,s CFO, Ms. Falberg will be...te finance, financial planning, investor relations...
Breaking Medicine Technology:Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3Determining Insulin Pump Need for Diabetics 52889 1Determining Insulin Pump Need for Diabetics 52889 2Raptor Pharmaceuticals Corp and TorreyPines Therapeutics Inc Announce Merger Agreement 52887 1Raptor Pharmaceuticals Corp and TorreyPines Therapeutics Inc Announce Merger Agreement 52887 2Raptor Pharmaceuticals Corp and TorreyPines Therapeutics Inc Announce Merger Agreement 52887 3Raptor Pharmaceuticals Corp and TorreyPines Therapeutics Inc Announce Merger Agreement 52887 4Raptor Pharmaceuticals Corp and TorreyPines Therapeutics Inc Announce Merger Agreement 52887 5Raptor Pharmaceuticals Corp and TorreyPines Therapeutics Inc Announce Merger Agreement 52887 6Raptor Pharmaceuticals Corp and TorreyPines Therapeutics Inc Announce Merger Agreement 52887 7Raptor Pharmaceuticals Corp and TorreyPines Therapeutics Inc Announce Merger Agreement 52887 8Employers See Well Designed Worksite Health and Wellness Programs as Strong Value in Down Economy 52884 1Employers See Well Designed Worksite Health and Wellness Programs as Strong Value in Down Economy 52884 2Employers See Well Designed Worksite Health and Wellness Programs as Strong Value in Down Economy 52884 3Employers See Well Designed Worksite Health and Wellness Programs as Strong Value in Down Economy 52884 4Employers See Well Designed Worksite Health and Wellness Programs as Strong Value in Down Economy 52884 5
...n To Affect 9-Fold More Longevity Genes Than Resve...t Alone - Independent Laboratory A...ers report that a,proprietary nutriceutical matrix...nes controlling energy metabolism, nine times broa...striction (mouse study --,Experimental Gerontology...
...se III Study Does Not Mean the End of Anti-Amyloid... studies,of potential new treatments for Alzheimer...l - increase the field,s knowledge and point scien..., according to research,reported today at the 2008...on Alzheimer,s Disease (ICAD 2008), in Chicago., ...
Other Medicine Technology:Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies 2Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies 3Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 2Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 3Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 4Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 5Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 6Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 7Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 8Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 9Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 10Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 11
Osher Lid Speculum
McKinney Eye Speculum
Mellinger Eye Speculum - Solid
Probst Lasik Speculum
Medicine Products: